Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors - Burris, KD; Molski, TF; Xu, C; Ryan, E; Tottori, K; Yocca, FD; Molinoff, PB (J Pharmacol Exp Ther, 2002)